These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19092271)

  • 1. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
    Hatanaka K; Kudo M; Minami Y; Maekawa K
    Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
    Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
    Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging.
    Abo T; Nanashima A; Tobinaga S; Hidaka S; Taura N; Takagi K; Arai J; Miyaaki H; Shibata H; Nagayasu T
    Eur J Surg Oncol; 2015 Feb; 41(2):257-64. PubMed ID: 25447030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer.
    Mishima M; Toh U; Iwakuma N; Takenaka M; Furukawa M; Akagi Y
    Breast Cancer; 2016 Mar; 23(2):231-41. PubMed ID: 25143060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Localisation of hepatic lesions to liver segments according to sonography (US), computed tomography (CT) and surgery (OP): a comparative study].
    Schacherer D; Decking D; Herold T; Obed A; Schlitt HJ; Gruene S; Schoelmerich J; Schlottmann K
    Z Gastroenterol; 2010 Feb; 48(2):241-5. PubMed ID: 20127599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy.
    Torzilli G; Minagawa M; Takayama T; Inoue K; Hui AM; Kubota K; Ohtomo K; Makuuchi M
    Hepatology; 1999 Oct; 30(4):889-93. PubMed ID: 10498639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ; Song B; Wu B; Xu J; Zhao LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
    Shah AJ; Parsons B; Pope I; Callaway M; Finch-Jones MD; Thomas MG
    Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions.
    Eso Y; Takai A; Takeda H; Matsumoto T; Lee M; Inuzuka T; Takahashi K; Ueda Y; Marusawa H; Seno H
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1462-1467. PubMed ID: 27623001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.